Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer

  Free Subscription


22.04.2019

1 Adv Anat Pathol
1 Anal Chem
1 Ann Glob Health
1 Biochem Biophys Res Commun
1 Biosci Rep
3 BMJ
1 Br J Cancer
1 Br J Clin Pharmacol
1 Cell Prolif
1 Clin Exp Dermatol
1 CMAJ Open
1 DNA Cell Biol
1 Eur J Surg Oncol
1 Eur Radiol
2 Exp Ther Med
1 Fam Community Health
1 Front Genet
1 Front Oncol
4 Gynecol Oncol
1 IEEE/ACM Trans Comput Biol Bioinform
1 Indian J Radiol Imaging
1 Infect Genet Evol
1 Int J Cancer
1 Int J Gynecol Pathol
1 Intern Med
2 J Cancer Prev
1 J Community Health
1 J Exp Clin Cancer Res
1 J Korean Med Sci
1 J Oncol
1 Lancet Glob Health
1 Medicine (Baltimore)
1 Nat Prod Res
1 Pathol Int
2 PLoS One
1 Prev Med
1 Rev Epidemiol Sante Publique
1 Sheng Wu Gong Cheng Xue Bao
1 Zhongguo Zhong Yao Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Anat Pathol

  1. PIROG EC, Park KJ, Kiyokawa T, Zhang X, et al
    Gastric-type Adenocarcinoma of the Cervix: Tumor With Wide Range of Histologic Appearances.
    Adv Anat Pathol. 2019;26:1-12.
    PubMed     Text format     Abstract available


    Anal Chem

  2. ZHU L, Wang C, Pang DW, Zhang ZL, et al
    Controlled Release of Therapeutic Agents with NIR Laser for Synergistic Photo-Chemotherapy towards Cervical Cancer.
    Anal Chem. 2019 Apr 17. doi: 10.1021/acs.analchem.8b05982.
    PubMed     Text format     Abstract available


    Ann Glob Health

  3. LIEBER M, Afzal O, Shaia K, Mandelberger A, et al
    Cervical Cancer Screening in HIV-Positive Farmers in South Africa: Mixed-Method Assessment.
    Ann Glob Health. 2019;85.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  4. XI C, Wang L, Yu J, Ye H, et al
    Inhibition of cyclin-dependent kinases by AT7519 is effective to overcome chemoresistance in colon and cervical cancer.
    Biochem Biophys Res Commun. 2019 Apr 10. pii: S0006-291X(19)30636.
    PubMed     Text format     Abstract available


    Biosci Rep

  5. GAO ZY, Liu X, Yang FM, Liu L, et al
    Octamer binding transcription factor-4 expression is associated with cervical cancer malignancy and histological differentiation: A systematic review and meta-analysis.
    Biosci Rep. 2019 Apr 12. pii: BSR20182328. doi: 10.1042/BSR20182328.
    PubMed     Text format     Abstract available


    BMJ

  6. LEI J, Andrae B, Ploner A, Lagheden C, et al
    Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study.
    BMJ. 2019;365:l1207.
    PubMed     Text format     Abstract available

  7. WISE J
    DIY smear tests: are they the answer to falling cervical screening rates?
    BMJ. 2019;364:l361.
    PubMed     Text format    

  8. PALMER T, Wallace L, Pollock KG, Cuschieri K, et al
    Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study.
    BMJ. 2019;365:l1161.
    PubMed     Text format     Abstract available


    Br J Cancer

  9. HORN J, Denecke A, Luyten A, Rothe B, et al
    Reduction of cervical cancer incidence within a primary HPV screening pilot project (WOLPHSCREEN) in Wolfsburg, Germany.
    Br J Cancer. 2019 Apr 16. pii: 10.1038/s41416-019-0453.
    PubMed     Text format     Abstract available


    Br J Clin Pharmacol

  10. ZHOU C, Taylor S, Tugwood J, Simpson K, et al
    Dynamics of circulating VEGF-A predict benefit from anti-angiogenic cediranib in metastatic or recurrent cervical cancer patients.
    Br J Clin Pharmacol. 2019 Apr 13. doi: 10.1111/bcp.13965.
    PubMed     Text format     Abstract available


    Cell Prolif

  11. ZHANG P, Zhang Y, Liu K, Liu B, et al
    Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway.
    Cell Prolif. 2019;52:e12543.
    PubMed     Text format     Abstract available


    Clin Exp Dermatol

  12. ABAK B, Gole P, Dongre A, Kharkar V, et al
    Syringocystadenoma papilliferum of the cervix presenting as vulvar growth in an adolescent girl.
    Clin Exp Dermatol. 2019;44:58-61.
    PubMed     Text format     Abstract available


    CMAJ Open

  13. DE POKOMANDY A, Burchell AN, Salters K, Ding E, et al
    Cervical cancer screening among women living with HIV: a cross-sectional study using the baseline questionnaire data from the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS).
    CMAJ Open. 2019;7:E217-E226.
    PubMed     Text format     Abstract available


    DNA Cell Biol

  14. MAO Y, Fu Z, Dong L, Zheng Y, et al
    Identification of a 26-lncRNAs Risk Model for Predicting Overall Survival of Cervical Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
    DNA Cell Biol. 2019;38:322-332.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  15. BONTE AS, Luyckx A, Wyckmans L, Trinh XB, et al
    Quality indicators for the management of endometrial, cervical and ovarian cancer.
    Eur J Surg Oncol. 2019;45:528-537.
    PubMed     Text format     Abstract available


    Eur Radiol

  16. GU KW, Kim CK, Choi CH, Yoon YC, et al
    Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy.
    Eur Radiol. 2019 Apr 12. pii: 10.1007/s00330-019-06204.
    PubMed     Text format     Abstract available


    Exp Ther Med

  17. ZHANG Y, Yang Y, Liu R, Meng Y, et al
    Downregulation of microRNA-425-5p suppresses cervical cancer tumorigenesis by targeting AIFM1.
    Exp Ther Med. 2019;17:4032-4038.
    PubMed     Text format     Abstract available

  18. SHI X, Xu M, Luo K, Huang W, et al
    Anticancer activity of bergenin against cervical cancer cells involves apoptosis, cell cycle arrest, inhibition of cell migration and the STAT3 signalling pathway.
    Exp Ther Med. 2019;17:3525-3529.
    PubMed     Text format     Abstract available


    Fam Community Health

  19. LEE J, Carvallo M, Lee E, Chung J, et al
    Affective and Cognitive Attitudes on Cervical Health Behaviors Among Asian American Women.
    Fam Community Health. 2019;42:123-132.
    PubMed     Text format     Abstract available


    Front Genet

  20. MAO Y, Dong L, Zheng Y, Dong J, et al
    Prediction of Recurrence in Cervical Cancer Using a Nine-lncRNA Signature.
    Front Genet. 2019;10:284.
    PubMed     Text format     Abstract available


    Front Oncol

  21. ZHONG X, Li J, Zhang L, Lu B, et al
    Characterization of Insufficiency Fracture and Bone Metastasis After Radiotherapy in Patients With Cervical Cancer Detected by Bone Scan: Role of Magnetic Resonance Imaging.
    Front Oncol. 2019;9:183.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  22. BOGANI G, Chiappa V, Vinti D, Somigliana E, et al
    Long-term results of fertility-sparing treatment for early-stage cervical cancer.
    Gynecol Oncol. 2019 Apr 16. pii: S0090-8258(19)30502.
    PubMed     Text format     Abstract available

  23. HALL MT, Smith MA, Lew JB, O'Hallahan J, et al
    The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
    Gynecol Oncol. 2019;152:472-479.
    PubMed     Text format     Abstract available

  24. SHEU J, Palileo A, Chen MY, Hoepner L, et al
    Hospice utilization in advanced cervical malignancies: An analysis of the National Inpatient Sample.
    Gynecol Oncol. 2019;152:594-598.
    PubMed     Text format     Abstract available

  25. PIGNATA S, Scambia G, Lorusso D, De Giorgi U, et al
    The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
    Gynecol Oncol. 2019 Apr 9. pii: S0090-8258(19)30495.
    PubMed     Text format     Abstract available


    IEEE/ACM Trans Comput Biol Bioinform

  26. PAUL S, Singh M
    RFCM3: Computational Method for Identification of miRNA-mRNA Regulatory Modules in Cervical Cancer.
    IEEE/ACM Trans Comput Biol Bioinform. 2019.
    PubMed     Text format     Abstract available


    Indian J Radiol Imaging

  27. DASHOTTAR S, Preeth Pany T, Lohia N
    Role of apparent diffusion coefficient as a biomarker in the evaluation of cervical cancer.
    Indian J Radiol Imaging. 2019;29:25-32.
    PubMed     Text format     Abstract available


    Infect Genet Evol

  28. ZHOU Z, Yang H, Yang L, Yao Y, et al
    Human papillomavirus type 16 E6 and E7 gene variations associated with cervical cancer in a Han Chinese population.
    Infect Genet Evol. 2019;73:13-20.
    PubMed     Text format     Abstract available


    Int J Cancer

  29. LEEMAN A, Del Pino M, Marimon L, Torne A, et al
    Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
    Int J Cancer. 2019;144:160-168.
    PubMed     Text format     Abstract available


    Int J Gynecol Pathol

  30. SPRIGGS CC, Blanco LZ, Maniar KP, Laimins LA, et al
    Expression of HPV-induced DNA Damage Repair Factors Correlates With CIN Progression.
    Int J Gynecol Pathol. 2019;38:1-10.
    PubMed     Text format     Abstract available


    Intern Med

  31. ISHIMARU N, Kanzawa Y, Seto H, Kinami S, et al
    Syphilitic Cervicitis with Cervical Cancer Presenting as Oropharyngeal Syphilis: A Case Report.
    Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.2426.
    PubMed     Text format     Abstract available


    J Cancer Prev

  32. LANGABEER SE
    "JAK2 V617F Mutation in Cervical Cancer Related to HPV & STIs" - Letter.
    J Cancer Prev. 2019;24:59-60.
    PubMed     Text format    

  33. SOHRABI A
    Response to Letter to Editor "JAK2 V617F Mutation in Cervical Cancer Related to HPV & STIs" by Stephen E. Langabeer.
    J Cancer Prev. 2019;24:61-62.
    PubMed     Text format    


    J Community Health

  34. TETEH DK, Dawkins-Moultin L, Robinson C, LaGroon V, et al
    Use of community forums to increase knowledge of HPV and cervical cancer in African American communities.
    J Community Health. 2019 Apr 15. pii: 10.1007/s10900-019-00665.
    PubMed     Text format     Abstract available


    J Exp Clin Cancer Res

  35. LI H, Zhang W, Yan M, Qiu J, et al
    Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt/beta-catenin signaling.
    J Exp Clin Cancer Res. 2019;38:33.
    PubMed     Text format     Abstract available


    J Korean Med Sci

  36. PYO JS, Kang G, Yoon HK, Kim HJ, et al
    Diagnostic Test Accuracy Review of Cytology for Squamous Intraepithelial Lesion and Squamous Cell Carcinoma of Uterine Cervix.
    J Korean Med Sci. 2019;34:e16.
    PubMed     Text format     Abstract available


    J Oncol

  37. FABRI VA, Queiroz ACM, Mantoan H, Sanches SM, et al
    The Impact of Addition of Consolidation Chemotherapy to Standard Cisplatin-Based Chemoradiotherapy in Uterine Cervical Cancer: Matter of Distant Relapse.
    J Oncol. 2019;2019:1217838.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  38. NEVIN PE, Garcia PJ, Blas MM, Rao D, et al
    Inequities in cervical cancer care in indigenous Peruvian women.
    Lancet Glob Health. 2019;7:e556-e557.
    PubMed     Text format    


    Medicine (Baltimore)

  39. CHEN Y, Xu Y, Wu D, Li Z, et al
    Survey of cervical cancer and precancerous lesion prevention knowledge within community health service centers in Shanghai, China.
    Medicine (Baltimore). 2019;98:e15002.
    PubMed     Text format     Abstract available


    Nat Prod Res

  40. CASTILLO-BAUTISTA CM, Torres-Tapia LW, Lagunas-Martinez A, Contreras-Ochoa CO, et al
    Secundiflorol G isolated from Aeschynomene fascicularis, a Mayan medicinal plant, induces apoptosis in cervical cancer cells.
    Nat Prod Res. 2019 Apr 16:1-3. doi: 10.1080/14786419.2019.1601092.
    PubMed     Text format     Abstract available


    Pathol Int

  41. NAKAJIMA T, Hatta H, Nishida T, Minamisaka T, et al
    Superficial spread of cervical squamous cell carcinoma to the upper genital tract and dissemination to the omentum.
    Pathol Int. 2019;69:119-121.
    PubMed     Text format    


    PLoS One

  42. CAMPOS RG, Malacara Rosas A, Gutierrez Santillan E, Delgado Gutierrez M, et al
    Unusual prevalence of high-risk genotypes of human papillomavirus in a group of women with neoplastic lesions and cervical cancer from Central Mexico.
    PLoS One. 2019;14:e0215222.
    PubMed     Text format     Abstract available

  43. WANG W, Liu X, Meng Q, Zhang F, et al
    Nomograms predicting survival and patterns of failure in patients with cervical cancer treated with concurrent chemoradiotherapy: A special focus on lymph nodes metastases.
    PLoS One. 2019;14:e0214498.
    PubMed     Text format     Abstract available


    Prev Med

  44. ISLAMI F, Fedewa SA, Jemal A
    Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States.
    Prev Med. 2019 Apr 16. pii: S0091-7435(19)30134.
    PubMed     Text format     Abstract available


    Rev Epidemiol Sante Publique

  45. CAPOROSSI A, Olicard C, Seigneurin A, Garnier A, et al
    [Interval between two smear tests for cervical cancer screening and characteristics of women with a short interval: Study in the department of Isere].
    Rev Epidemiol Sante Publique. 2019 Apr 10. pii: S0398-7620(19)30297.
    PubMed     Text format     Abstract available


    Sheng Wu Gong Cheng Xue Bao

  46. FU W, Hou G, Huang D
    [Long non-coding RNA and cervical cancer].
    Sheng Wu Gong Cheng Xue Bao. 2019;35:598-606.
    PubMed     Text format     Abstract available


    Zhongguo Zhong Yao Za Zhi

  47. SU M, Gong XJ, Zhou X
    [Research progress in mechanism of traditional Chinese medicine active ingredients against cervical cancer].
    Zhongguo Zhong Yao Za Zhi. 2019;44:675-684.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: